IP Library Granted Patent US 10,806,726
Granted Patent B2
US 10,806,726 · App. 15/790,544 · Granted Oct 20, 2020

Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors

Inventors: Vishal Deshmukh (San Diego, CA); Eric Anthony Murphy (San Marcos, CA); John Hood (San Diego, CA)
Assignee: Samumed, LLC
A61K31/444A61K31/4439A61K31/4545A61K31/496A61K31/501A61K31/5355A61K31/5377A61P17/00A61P17/06A61P19/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,806,726
App. No.
15/790,544
Granted
Oct 20, 2020
Kind
B2
Abstract

This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.

Claims (4)

1. A method of treating tendinopathy, the method comprising administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of a compound or pharmaceutically acceptable salt thereof having the structure of:

2. The method of claim 1 , wherein the tendinopathy is tendinosis.

3. The method of claim 1 , wherein the tendinopathy is tendinitis.

4. The method of claim 1 , wherein the tendinopathy is tenosynovitis.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2026
From: TMF GROUP NEW YORK, LLC, NOT INDIVIDUALLY BUT SOLELY AS COLLATERAL AGENT
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 075109/0434 →
SECURITY INTEREST Recorded Sep 14, 2022
From: BIOSPLICE THERAPEUTICS, INC.
To: VICKERS VENTURE FUND VI PTE. LTD.; VICKERS VENTURE FUND VI (PLAN) PTE. LTD.; VICKERS-SPLICE CO-INVESTMENT LLC; MED-PATHWAYS II LIMITED
Reel/Frame 061433/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 055693/0809 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2017
From: DESHMUKH, VISHAL; MURPHY, ERIC ANTHONY; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 044194/0419 →
Continuity (2)
Provisional Application 62411478 · Oct 21, 2016
Related Publication 20180185343A1 · Jul 5, 2018